Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe input indicates no changes to add or remove on the page; thus the page content remains as currently published.SummaryDifference0.0%

- Check13 days agoChange DetectedA new Publication entry was added under Publications: Armstrong AW, Lebwohl M, Warren RB, Morita A, Paul C, Thaci D, Augustin M, Puig L, Daamen C, Li J, Alio A, Aggrey-Amable A, Scotto J, Popmihajlov Z, Vaile J, Strober B. Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials, Am J Clin Dermatol, 2026 Aug 7 (online ahead of print).SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's metadata/documentation. This appears to be a routine version bump rather than a change to study content or patient-facing information.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision line updated from v3.6.3 to v3.6.4, indicating a newer version in the page's revision history.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.0 tag to reflect a newer version.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page adds a recruitment-status notice and new user guidance sections, along with a UI revision note indicating the version change.SummaryDifference0.1%

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.